Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 777 (ZNF777) is a human transcription factor belonging to the KRAB-ZFP (Krüppel-associated box-containing zinc finger protein) family. It contains a KRAB domain that interacts with transcriptional corepressors and multiple zinc finger domains that bind DNA in a sequence-specific manner, regulating transcription via RNA polymerase II. ZNF777 localizes to the nucleus and is involved in the negative regulation of cell proliferation, particularly in cancer cell biology, where its overexpression can inhibit proliferation by down-regulating FAM129A and inducing cell cycle inhibitor p21. The gene is located on chromosome 7 and expressed in several tissues. Despite its biological relevance, ZNF777 is not currently recognized as a direct target for therapeutic drugs or intervention.
Not applicable (no drugs known to target ZNF777).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 777 (ZNF777).